SCHEMBL985772

SCHEMBL985772

CC(C)Oc1c(Cl)cc(C(=O)Cl)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 2/20 0.40
ALDH1A1 P00352 5/20 0.40
TPMT P51580 1/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
PLAU P00749 2/20 0.39
GLRA1 P23415 1/20 0.39
RORC P51449 1/20 0.38
TAS1R3 Q7RTX0 1/20 0.37
TAS1R1 Q7RTX1 1/20 0.37
TAS1R2 Q8TE23 1/20 0.37
HTT P42858 2/20 0.37
TP53 P04637 1/20 0.37
ALOX12 P18054 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
THRA P10827 1/20 0.37
THRB P10828 1/20 0.37
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1573045 0.85 TPMT (0.56) PPARAALDH1A1TPMTKDM4EGAA
SCHEMBL3949729 0.81 PPARA (0.46) PPARAALDH1A1TPMTKDM4EGAA
SCHEMBL985523 0.78 ALDH1A1 (0.61) ALDH1A1TPMTKDM4EGAATAS1R3
SCHEMBL4238364 0.78 CA12 (0.50) PPARAALDH1A1HTTKMT2ALMNA
SCHEMBL1014238 0.77 RORC (0.56) RORCTAS1R3TAS1R1KMT2ALMNA
SCHEMBL1814578 0.76 KMT2A (0.47) ALDH1A1GAAPLAUGLRA1HTT
SCHEMBL1459275 0.75 TPMT (0.50) ALDH1A1TPMTPLAURORCHTT
SCHEMBL19088279 0.74 GAA (0.42) ALDH1A1GAARORCHTTTP53
SCHEMBL31582335 0.74 ABCB11 (0.41) ALDH1A1TPMTKDM4EGAAPLAU
SCHEMBL1013088 0.74 RORC (0.42) RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7875631-B2 e.g.1-(3,5-dichlorophenyl)-2-formyl-6-methoxy-1,2,3,4-tetrahydroisoquinoline; to prevent and/or treat cancer and other abnormal cell growth, and metabolic as well as blood vessel proliferate disorders, in which uncontrolled expression of insulin-like growth factor-1 receptor is observed ANALYTECON S.A. (CH) 2011-01-25 US disclosed